SCHEMBL31504533

SCHEMBL31504533

CC(C)[Si](C#Cc1nc([S+](C)[O-])ncc1Cl)(C(C)C)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31504543 0.72 KMT2A (0.44) —
SCHEMBL31504542 0.72 KMT2A (0.44) —
SCHEMBL30921337 0.69 — —
SCHEMBL27992091 0.68 DYRK1A (0.30) —
SCHEMBL30879089 0.68 KDM4E (0.33) —
SCHEMBL7071462 0.64 TDP1 (0.45) —
SCHEMBL28042369 0.63 CDK1 (0.34) —
SCHEMBL19145398 0.62 — —
SCHEMBL10973806 0.62 — —
SCHEMBL29184313 0.61 KDM4E (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025060620-A1 CDK KINASE INHIBITOR AND USE THEREOF 上海和誉生物医药科技有限公司 2025-03-27 — — WO disclosed
Send feedback